The Study of Cognitive Rehabilitation Effectiveness for Mild Traumatic Brain Injury (SCORE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2013 by Brooke Army Medical Center
Sponsor:
Collaborators:
The Defense and Veterans Brain Injury Center
Henry M. Jackson Foundation for the Advancement of Military Medicine
Information provided by (Responsible Party):
Amy Bowles, M.D., Brooke Army Medical Center
ClinicalTrials.gov Identifier:
NCT01339806
First received: April 15, 2011
Last updated: February 20, 2013
Last verified: February 2013
  Purpose

The objective of this trial is to evaluate the effectiveness of cognitive rehabilitation in OIF/OEF service members with a history of mild traumatic brain injury and persistent (3-24 months post injury) cognitive complaints. This is a prospective, randomized, control treatment trial of cognitive rehabilitation for OEF/OIF Service Members with a history of mild traumatic brain injury (mTBI) and persistent (3-24 months post-injury) cognitive complaints. Subjects will be recruited from consecutive patient referrals to the TBI Service at SAMMC-North. Patients who meet eligibility criteria and consent to participate in the treatment trial will be randomly assigned to one of four, 6-week treatment arms of the study. Subjects will be evaluated prior to the start of treatment and 3, 6, 12, and 18 weeks following the initiation of the study. The total number of patients to be studied is 160 (maximum), which is approximately 20 patients per month.


Condition Intervention Phase
Traumatic Brain Injury With Brief Loss of Consciousness
Traumatic Brain Injury With No Loss of Consciousness
Behavioral: Cognitive Rehab
Behavioral: Brainworks
Behavioral: Informational Handout/Provider Visits
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Phase IV Study of Cognitive Rehabilitation Effectiveness for Mild Traumatic Brain Injury

Resource links provided by NLM:


Further study details as provided by Brooke Army Medical Center:

Primary Outcome Measures:
  • Emotional Functioning [ Time Frame: Baseline ] [ Designated as safety issue: No ]

    Symptom Checklist-90-Revised (SCL-90-R)

    Global Severity Index and 9 subscales:

    Somatization; Obsessive-Compulsive; Interpersonal Sensitivity; Depression; Anxiety; Hostility; Phobic Anxiety; Paranoid Ideation, and Psychoticism


  • Cognitive Efficiency [ Time Frame: Baseline ] [ Designated as safety issue: No ]

    Paced Auditory Serial Addition Test (PASAT)

    • correct trial 1
    • correct trial 2
    • correct trial 3
    • correct trial 4 Sum of trials 1-4

  • Functional Behaviors [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Key Behaviors Change Inventory (KBCI) Total score Inattention- raw & T-score Impulsivity- raw & T-score Unawareness of Problems - raw & T-score Apathy - raw & T-score Interpersonal Difficulties - raw & T-score Communication Problems - raw & T-score Somatic Difficulties - raw & T-score Emotional Adjustment - raw & T-score 64 individual items

  • Emotional Functioning [ Time Frame: 3 Weeks ] [ Designated as safety issue: No ]

    Symptom Checklist-90-Revised (SCL-90-R)

    Global Severity Index and 9 subscales:

    Somatization; Obsessive-Compulsive; Interpersonal Sensitivity; Depression; Anxiety; Hostility; Phobic Anxiety; Paranoid Ideation, and Psychoticism


  • Emotional Functioning [ Time Frame: 6 Weeks ] [ Designated as safety issue: No ]

    Symptom Checklist-90-Revised (SCL-90-R)

    Global Severity Index and 9 subscales:

    Somatization; Obsessive-Compulsive; Interpersonal Sensitivity; Depression; Anxiety; Hostility; Phobic Anxiety; Paranoid Ideation, and Psychoticism


  • Emotional Functioning [ Time Frame: 12 Weeks ] [ Designated as safety issue: No ]

    Symptom Checklist-90-Revised (SCL-90-R)

    Global Severity Index and 9 subscales:

    Somatization; Obsessive-Compulsive; Interpersonal Sensitivity; Depression; Anxiety; Hostility; Phobic Anxiety; Paranoid Ideation, and Psychoticism


  • Emotional Functioning [ Time Frame: 18 Weeks ] [ Designated as safety issue: No ]

    Symptom Checklist-90-Revised (SCL-90-R)

    Global Severity Index and 9 subscales:

    Somatization; Obsessive-Compulsive; Interpersonal Sensitivity; Depression; Anxiety; Hostility; Phobic Anxiety; Paranoid Ideation, and Psychoticism


  • Cognitive Efficiency [ Time Frame: 3 Weeks ] [ Designated as safety issue: No ]

    Paced Auditory Serial Addition Test (PASAT)

    • correct trial 1
    • correct trial 2
    • correct trial 3
    • correct trial 4 Sum of trials 1-4

  • Cognitive Efficiency [ Time Frame: 6 Weeks ] [ Designated as safety issue: No ]

    Paced Auditory Serial Addition Test (PASAT)

    • correct trial 1
    • correct trial 2
    • correct trial 3
    • correct trial 4 Sum of trials 1-4

  • Cognitive Efficiency [ Time Frame: 12 Weeks ] [ Designated as safety issue: No ]

    Paced Auditory Serial Addition Test (PASAT)

    • correct trial 1
    • correct trial 2
    • correct trial 3
    • correct trial 4 Sum of trials 1-4

  • Cognitive Efficiency [ Time Frame: 18 Weeks ] [ Designated as safety issue: No ]

    Paced Auditory Serial Addition Test (PASAT)

    • correct trial 1
    • correct trial 2
    • correct trial 3
    • correct trial 4 Sum of trials 1-4

  • Functional Behaviors [ Time Frame: 3 Weeks ] [ Designated as safety issue: No ]
    Key Behaviors Change Inventory (KBCI) Total score Inattention- raw & T-score Impulsivity- raw & T-score Unawareness of Problems - raw & T-score Apathy - raw & T-score Interpersonal Difficulties - raw & T-score Communication Problems - raw & T-score Somatic Difficulties - raw & T-score Emotional Adjustment - raw & T-score 64 individual items

  • Functional Behaviors [ Time Frame: 6 Weeks ] [ Designated as safety issue: No ]
    Key Behaviors Change Inventory (KBCI) Total score Inattention- raw & T-score Impulsivity- raw & T-score Unawareness of Problems - raw & T-score Apathy - raw & T-score Interpersonal Difficulties - raw & T-score Communication Problems - raw & T-score Somatic Difficulties - raw & T-score Emotional Adjustment - raw & T-score 64 individual items

  • Functional Behaviors [ Time Frame: 12 Weeks ] [ Designated as safety issue: No ]
    Key Behaviors Change Inventory (KBCI) Total score Inattention- raw & T-score Impulsivity- raw & T-score Unawareness of Problems - raw & T-score Apathy - raw & T-score Interpersonal Difficulties - raw & T-score Communication Problems - raw & T-score Somatic Difficulties - raw & T-score Emotional Adjustment - raw & T-score 64 individual items

  • Functional Behaviors [ Time Frame: 18 Weeks ] [ Designated as safety issue: No ]
    Key Behaviors Change Inventory (KBCI) Total score Inattention- raw & T-score Impulsivity- raw & T-score Unawareness of Problems - raw & T-score Apathy - raw & T-score Interpersonal Difficulties - raw & T-score Communication Problems - raw & T-score Somatic Difficulties - raw & T-score Emotional Adjustment - raw & T-score 64 individual items


Secondary Outcome Measures:
  • Fatigue [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Fatigue Severity Scale (FSS) Total Raw scale 9 individual items

  • Post-Concussive Symptoms [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Neurobehavioral Symptom Inventory Total Raw scale 22 individual items

  • Self Reported Quality of Life [ Time Frame: Baseline ] [ Designated as safety issue: No ]

    World Health Organization Brief Quality of Life Scale (WHO-QOL-BREF) Total transformed score

    Total score for each of the 5 subscale domains:

    Overall Functioning Physical Capacity Psychological Social Relationships Environment


  • Neuropsychological Status [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Neuropsychological Global Composite Score Average normative t-score of: [CVLT-2 sum trials 1-5, D-KEFS Verbal Fluency total score, Trail Making Test - part B only, WAIS-IV Processing Speed, Working, CVLT- 2 Trial 1, CVLT-2 Trial 2, CVLT- 2 Trial 3, CVLT-2 Trial 4, CVLT-2 Trial 5, CVLT-2 Total Trials 1-5, CVLT-2 Total Trials 1-5 (T-score), CVLT-2 List B, SDFR, SDCR, LDFR, LDCR, total perseverations,total intrusions CVLT-2 LD recognition hits CVLT-2 LD recognition FP errors Trails part A, Trails part B, Trails part A, Trails part B, WAIS-IV Processing Speed Index, WAIS-IV Symbol Search

  • Self Reported Alcohol Use Behaviors [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Alcohol Use Disorders Identification Test (AUDIT) Summary Socre; 10 individual items

  • Post-Traumatic Stress Symptomatology [ Time Frame: 18 Weeks ] [ Designated as safety issue: No ]
    Post-Traumatic Stress Checkilist-Military Form (PCL-M) Total Raw Socre 17 items

  • Self Reported Headache Disability [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Headache Impact Test-6 (HIT-6) Total Weighted Score

  • Health Related (Cognition) Locus of Control [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Multidimensional Health Locus of Control Scale (MHLCS-Form C) Internal subscale-total raw Chance subscale-total raw Powerful others subscale-total raw Doctors subscale-total raw Other people subscale-total raw

  • Perceived Self-Efficacy (Cognition) [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Self-Efficacy for Symptom Management Scale SEsx total SEsocial subscale SEemotional subscale SEcognitvie subscale 13 individual items

  • Attribution of Cognitive Symptoms [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Cognitive Symptom Attribution Scale 7 individual items

  • Therapist-Rated Patient Engagement in Treatment [ Time Frame: Week 6 of treatment ] [ Designated as safety issue: No ]
    Rehabilitation Intensity of Therapy Scale (RITS) Weekly average rating (weeks 1-6)

  • Post-Concussive Symptoms [ Time Frame: 6 Weeks ] [ Designated as safety issue: No ]
    Neurobehavioral Symptom Inventory (NSI) Total Raw scale 22 individual items

  • Post-Concussive Symptoms [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    Neurobehavioral Symptom Inventory (NSI) Total Raw scale 22 individual items

  • Post-Concussive Symptoms [ Time Frame: 18 weeks ] [ Designated as safety issue: No ]
    Neurobehavioral Symptom Inventory (NSI) Total Raw scale 22 individual items

  • Fatigue [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    Fatigue Severity Scale (FSS) Total Raw scale 9 individual items

  • Fatigue [ Time Frame: 12 Weeks ] [ Designated as safety issue: No ]
    Fatigue Severity Scale (FSS) Total Raw scale 9 individual items

  • Fatigue [ Time Frame: 18 Weeks ] [ Designated as safety issue: No ]
    Fatigue Severity Scale (FSS) Total Raw scale 9 individual items

  • Change in Healthcare Utilization [ Time Frame: 30 days prior to Baseline and 6 months post Baseline ] [ Designated as safety issue: No ]
    Summed total number of appointments 30 days prior to study enrollment and summed total number of appointments for 30 days between 5 and 6 months post-treatment.

  • Self Reported Quality of Life [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]

    World Health Organization Brief Quality of Life Scale (WHO-QOL-BREF) Total transformed score

    Total score for each of the 5 subscale domains:

    Overall Functioning Physical Capacity Psychological Social Relationships Environment


  • Self Reported Quality of Life [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]

    World Health Organization Brief Quality of Life Scale (WHO-QOL-BREF) Total transformed score

    Total score for each of the 5 subscale domains:

    Overall Functioning Physical Capacity Psychological Social Relationships Environment


  • Self Reported Quality of Life [ Time Frame: 18 weeks ] [ Designated as safety issue: No ]

    World Health Organization Brief Quality of Life Scale (WHO-QOL-BREF) Total transformed score

    Total score for each of the 5 subscale domains:

    Overall Functioning Physical Capacity Psychological Social Relationships Environment


  • Neuropsychological Status [ Time Frame: 6 Weeks ] [ Designated as safety issue: No ]
    Neuropsychological Global Composite Score Average normative t-score of: [CVLT-2 sum trials 1-5, D-KEFS Verbal Fluency total score, Trail Making Test - part B only, WAIS-IV Processing Speed, Working, CVLT- 2 Trial 1, CVLT-2 Trial 2, CVLT- 2 Trial 3, CVLT-2 Trial 4, CVLT-2 Trial 5, CVLT-2 Total Trials 1-5, CVLT-2 Total Trials 1-5 (T-score), CVLT-2 List B, SDFR, SDCR, LDFR, LDCR, total perseverations,total intrusions CVLT-2 LD recognition hits CVLT-2 LD recognition FP errors Trails part A, Trails part B, Trails part A, Trails part B, WAIS-IV Processing Speed Index, WAIS-IV Symbol Search

  • Neuropsychological Status [ Time Frame: 12 Weeks ] [ Designated as safety issue: No ]
    Neuropsychological Global Composite Score Average normative t-score of: [CVLT-2 sum trials 1-5, D-KEFS Verbal Fluency total score, Trail Making Test - part B only, WAIS-IV Processing Speed, Working, CVLT- 2 Trial 1, CVLT-2 Trial 2, CVLT- 2 Trial 3, CVLT-2 Trial 4, CVLT-2 Trial 5, CVLT-2 Total Trials 1-5, CVLT-2 Total Trials 1-5 (T-score), CVLT-2 List B, SDFR, SDCR, LDFR, LDCR, total perseverations,total intrusions CVLT-2 LD recognition hits CVLT-2 LD recognition FP errors Trails part A, Trails part B, Trails part A, Trails part B, WAIS-IV Processing Speed Index, WAIS-IV Symbol Search

  • Neuropsychological Status [ Time Frame: 18 Weeks ] [ Designated as safety issue: No ]
    Neuropsychological Global Composite Score Average normative t-score of: [CVLT-2 sum trials 1-5, D-KEFS Verbal Fluency total score, Trail Making Test - part B only, WAIS-IV Processing Speed, Working, CVLT- 2 Trial 1, CVLT-2 Trial 2, CVLT- 2 Trial 3, CVLT-2 Trial 4, CVLT-2 Trial 5, CVLT-2 Total Trials 1-5, CVLT-2 Total Trials 1-5 (T-score), CVLT-2 List B, SDFR, SDCR, LDFR, LDCR, total perseverations,total intrusions CVLT-2 LD recognition hits CVLT-2 LD recognition FP errors Trails part A, Trails part B, Trails part A, Trails part B, WAIS-IV Processing Speed Index, WAIS-IV Symbol Search

  • Self Reported Alcohol Use Behaviors [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    Alcohol Use Disorders Identification Test (AUDIT) Summary Socre; 10 individual items

  • Self Reported Alcohol Use Behaviors [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    Alcohol Use Disorders Identification Test (AUDIT) Summary Socre; 10 individual items

  • Self Reported Alcohol Use Behaviors [ Time Frame: 18 weeks ] [ Designated as safety issue: No ]
    Alcohol Use Disorders Identification Test (AUDIT) Summary Socre; 10 individual items

  • Post-Traumatic Stress Symptomatology [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    Post-Traumatic Stress Checkilist-Military Form (PCL-M) Total Raw Socre 17 items

  • Post-Traumatic Stress Symptomatology [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Post-Traumatic Stress Checkilist-Military Form (PCL-M) Total Raw Socre 17 items

  • Post-Traumatic Stress Symptomatology [ Time Frame: 12 Weeks ] [ Designated as safety issue: No ]
    Post-Traumatic Stress Checkilist-Military Form (PCL-M) Total Raw Socre 17 items

  • Self Reported Headache Disability [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    Headache Impact Test-6 (HIT-6) Total Weighted Score

  • Self Reported Headache Disability [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    Headache Impact Test-6 (HIT-6) Total Weighted Score

  • Self Reported Headache Disability [ Time Frame: 18 Weeks ] [ Designated as safety issue: No ]
    Headache Impact Test-6 (HIT-6) Total Weighted Score

  • Health Related (Cognition) Locus of Control [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    Multidimensional Health Locus of Control Scale (MHLCS-Form C) Internal subscale-total raw Chance subscale-total raw Powerful others subscale-total raw Doctors subscale-total raw Other people subscale-total raw

  • Health Related (Cognition) Locus of Control [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    Multidimensional Health Locus of Control Scale (MHLCS-Form C) Internal subscale-total raw Chance subscale-total raw Powerful others subscale-total raw Doctors subscale-total raw Other people subscale-total raw

  • Health Related (Cognition) Locus of Control [ Time Frame: 18 weeks ] [ Designated as safety issue: No ]
    Multidimensional Health Locus of Control Scale (MHLCS-Form C) Internal subscale-total raw Chance subscale-total raw Powerful others subscale-total raw Doctors subscale-total raw Other people subscale-total raw

  • Perceived Self-Efficacy (Cognition) [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    Self-Efficacy for Symptom Management Scale SEsx total SEsocial subscale SEemotional subscale SEcognitvie subscale 13 individual items

  • Perceived Self-Efficacy (Cognition) [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    Self-Efficacy for Symptom Management Scale SEsx total SEsocial subscale SEemotional subscale SEcognitvie subscale 13 individual items

  • Perceived Self-Efficacy (Cognition) [ Time Frame: 18 weeks ] [ Designated as safety issue: No ]
    Self-Efficacy for Symptom Management Scale SEsx total SEsocial subscale SEemotional subscale SEcognitvie subscale 13 individual items

  • Attribution of Cognitive Symptoms [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    Cognitive Symptom Attribution Scale 7 individual items

  • Attribution of Cognitive Symptoms [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    Cognitive Symptom Attribution Scale 7 individual items

  • Attribution of Cognitive Symptoms [ Time Frame: 18 weeks ] [ Designated as safety issue: No ]
    Cognitive Symptom Attribution Scale 7 individual items

  • Therapist-Rated Patient Engagement in Treatment [ Time Frame: Week 1 of Treatment ] [ Designated as safety issue: No ]
    Rehabilitation Intensity of Therapy Scale (RITS) Weekly average rating (weeks 1-6)

  • Therapist-Rated Patient Engagement in Treatment [ Time Frame: Week 2 of treatment ] [ Designated as safety issue: No ]
    Rehabilitation Intensity of Therapy Scale (RITS) Weekly average rating (weeks 1-6)

  • Therapist-Rated Patient Engagement in Treatment [ Time Frame: Week 3 of treatment ] [ Designated as safety issue: No ]
    Rehabilitation Intensity of Therapy Scale (RITS) Weekly average rating (weeks 1-6)

  • Therapist-Rated Patient Engagement in Treatment [ Time Frame: Week 4 of treatment ] [ Designated as safety issue: No ]
    Rehabilitation Intensity of Therapy Scale (RITS) Weekly average rating (weeks 1-6)

  • Therapist-Rated Patient Engagement in Treatment [ Time Frame: Week 5 of treatment ] [ Designated as safety issue: No ]
    Rehabilitation Intensity of Therapy Scale (RITS) Weekly average rating (weeks 1-6)


Estimated Enrollment: 160
Study Start Date: June 2011
Estimated Study Completion Date: August 2014
Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Standard of Care for mTBI Provider Arm
Arm 1: Psychoeducational Control Group. Individuals assigned to arm 1 will receive psychoeducational materials specifically adapted for persistent management of symptoms and routine follow-up with medical providers (every three weeks). Additionally, subjects assigned to this group will receive medical care (e.g., psychopharmacological management of depression) and/or referral for symptom management (e.g., vestibular rehabilitation) of non-cognitive complaints, consistent with the current standard of care treatment model for managing post-concussive symptoms (see Figure below adapted with permission from authors; Brenner et al., 2009).
Behavioral: Informational Handout/Provider Visits
Provider based visits every three weeks and informational handout given to patient in regulation with current standard of care procedures.
Experimental: Computer Based Therapy Group
Arm 2: Non-therapist directed computerized cognitive rehabilitation. Individuals assigned to treatment arm 2 will receive ten hours of in-clinic, computerized treatment per week throughout the 6-week treatment trial. Participants will be scheduled for 2 hours per day, proctored by clinic staff (certified recreation therapist or neuropsychology technician) who will be responsible for recording daily performance, providing positive reinforcement of participation, and effort. Computer programs selected for this treatment trial include both skill-specific training (e.g., attention processes) and general cognitive activation. These computer programs are commercially available and advertised as "brain fitness" or "brain training."
Behavioral: Brainworks
POSIT
Other Name: POSIT
Behavioral: Informational Handout/Provider Visits
Provider based visits every three weeks and informational handout given to patient in regulation with current standard of care procedures.
Experimental: Cognitive Rehab Group
Arm 3: Therapist-directed individualized cognitive rehabilitation. Individuals assigned to treatment arm 3 will receive 10 hours of individual and group cognitive rehabilitation treatment (including homework assignments) per week conducted by credentialed speech therapists and occupational therapists. The treatment components will include five hours of weekly individual therapy (one-hour sessions; two hours focused on compensatory strategies and three hours focused on restorative strategies), two hours of weekly group therapy (one hour sessions focused on compensatory strategies), and three hours of weekly computer-based "homework" proctored by clinic staff who will be responsible for recording performance, and providing positive reinforcement of participation and effort.
Behavioral: Cognitive Rehab
APT-III, Other standard individual and group interventions.
Other Name: APT-III
Behavioral: Informational Handout/Provider Visits
Provider based visits every three weeks and informational handout given to patient in regulation with current standard of care procedures.
Experimental: Cognitive and Psychological Based Rehab
Arm 4: Integrated interdisciplinary cognitive rehabilitation combined with cognitive-behavioral psychotherapy. Individuals assigned to treatment arm 4 will receive 10 hours of individual and group treatment per week conducted by credentialed therapists and doctoral-level psychologists. The treatment components will include four hours of weekly 1 hr individual therapy sessions; 2 hrs of cognitive rehabilitation, 1 hr of cognitive rehab & 1 hr of individual psychotherapy targeting anxiety/combat stress symptoms including relaxation training & exposure therapy and cognitive-behavioral principles, 3 hrs of weekly group therapy & three hours of weekly "homework" including 30-mins relaxation training, 30-mins cognitive-behavioral psychotherapy homework, and 2 hrs of computerized cognitive rehabilitation exercises proctored by clinic staff.
Behavioral: Cognitive Rehab
APT-III, Other standard individual and group interventions.
Other Name: APT-III
Behavioral: Informational Handout/Provider Visits
Provider based visits every three weeks and informational handout given to patient in regulation with current standard of care procedures.

Detailed Description:

This is a prospective, randomized, control treatment trial of cognitive rehabilitation for OEF/OIF Service Members with a history of mild traumatic brain injury (mTBI) and persistent (3-24 months post-injury) cognitive complaints. Subjects will be recruited from consecutive patient referrals to the TBI Service at SAMMC-North. Patients who meet eligibility criteria and consent to participate in the treatment trial will be randomly assigned to one of four, 6-week treatment arms of the study: 1. Psychoeducational control group; 2. Non-therapist directed, computerized cognitive rehabilitation; 3. Therapist-directed individualized cognitive rehabilitation; and 4. Integrated interdisciplinary cognitive rehabilitation combined with cognitive-behavioral psychotherapy. (Components of the treatment arms are described in detail in section 4.6; Research Design and Methods.) All subjects enrolled in the study will receive the standard of care in management of chronic post-concussive symptoms, consistent with the VA/DoD Clinical Practice Guidelines for the Management of Concussion/mild TBI (Barth et al., 2009), regardless of treatment assignment. The standard of care includes provision of patient education materials (adapted from existing studies to address more persistent rather than acute symptom management), regular scheduled follow-up with a medical provider every three weeks, and symptom-based treatment of post-concussive complaints (e.g., medication trials for headache and co-occurring psychiatric disorders, physical therapy for vestibular complaints, case management, and supportive counseling with social work for soldiers assigned to the Warriors-in-Transition Battalion). Study participants who are assigned to treatment arms 2, 3, or 4 will additionally receive manualized cognitive rehabilitation therapies during the 6-week treatment phase of the study. Cognitive rehabilitation treatment intensity (i.e., number of hours of treatment per week) will be matched for individuals assigned to treatment arms 2, 3, or 4. Participants assigned to the control treatment group (treatment arm 1) will be offered individualized cognitive rehabilitation therapy if their cognitive complaints do not abate following the completion of the six-week treatment trial.

Study participants will be evaluated prior to the initiation of treatment, as well as at 3-weeks, 6-weeks, 12-weeks, and 18-weeks following the start of treatment. Study evaluators will be blind to treatment assignment. Pre-treatment baseline assessments and peri-/post-treatment outcome assessments will include demographic information, injury-related variables, self-report inventories, performance on neuropsychological testing, and functional status (e.g., work status; healthcare utilization). Detailed descriptions of the data to be collected including primary and secondary outcome measures, as well as co-variate measures can be found in section 4.8: Instrumentation.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of mTBI as defined in the VA/DoD Clinical Practice Guidelines for the Management of Concussion/mild TBI (Barth et al., 2009) which occurred during deployment in support of OEF/OIF within 3-24 months of study enrollment;
  • Presence of cognitive complaints (NSI score of 3 or higher on any of the four cognitive symptoms)
  • Ability to understand and communicate in English.

Exclusion Criteria:

  • Medical/psychiatric/neurologic co-morbidities of: blindness/low vision; uncontrolled seizure disorder; psychosis; history of moderate, severe TBI or penetrating BI; or Spinal Cord Injury with no use of upper extremities;
  • Active participation in intensive (> 5 appointments per week) treatment for amputation, orthopedic trauma, burns, substance abuse, or post-traumatic stress disorder which would preclude full participation in an intensive cognitive rehabilitation program; or
  • Daily use of narcotic pain medication(s).
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01339806

Contacts
Contact: Janel L Primus, MPAS, MS 210-916-8693 janel.l.primus@us.army.mil

Locations
United States, Texas
Brooke Army Medical Center Recruiting
San Antonio, Texas, United States, 78234
Contact: Janel L Primus, MPAS, MS    210-916-1874    janel.l.primus@us.army.mil   
Sub-Investigator: Douglas B Cooper, Ph.D.         
Principal Investigator: Amy O Bowles, MD         
Sub-Investigator: Jan Kennedy, PhD         
Sub-Investigator: Glenn Curtiss, PhD         
Sub-Investigator: Rodney Vanderploeg, PhD         
Sponsors and Collaborators
Brooke Army Medical Center
The Defense and Veterans Brain Injury Center
Henry M. Jackson Foundation for the Advancement of Military Medicine
Investigators
Principal Investigator: Amy O Bowles, MD BAMC
  More Information

Additional Information:
No publications provided

Responsible Party: Amy Bowles, M.D., TBI Service Chief, Brooke Army Medical Center
ClinicalTrials.gov Identifier: NCT01339806     History of Changes
Other Study ID Numbers: C.2010.199
Study First Received: April 15, 2011
Last Updated: February 20, 2013
Health Authority: United States: Federal Government

Keywords provided by Brooke Army Medical Center:
mTBI
Concussion

Additional relevant MeSH terms:
Brain Injuries
Unconsciousness
Wounds and Injuries
Consciousness Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Brain Diseases
Central Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System

ClinicalTrials.gov processed this record on August 26, 2014